| PsA | Psoriasis arthritis |
| PASI | Psoriasis area severity index |
| TNF | Tumor necrosis factor |
| IL | Interleukin |
| DNA | Deoxyribonucleic acid |
| IFN | Interferon |
| CD | Cluster of differentiation |
| CXCL | Chemokine (C–X–C motif) ligand |
| CCL | Chemokine (C–C motif) ligand |
| FDA | Food and Drug Administration |
| PGA | Physician Global Assessment |
| LFA | Lymphocyte function–associated antigen |
| Ig | Immunoglobulin |
| APC | Antigen presenting cell |
| I.M. | Intra-muscular |
| I.V. | Intra-venous |
| ICAM | Intercellular Adhesion Molecule |
| PCL | Progressive multifocal leukoencephalopathy |
| ADA | Anti-drug-antibodies |
| TB | Tuberculosis |